Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05912556 · ClinicalTrials.gov registry record · NA

Brain Response to an Intervention Using Guided, At-Home Technology for the Mind

A NA study of Cognition and Brain Function, sponsored by Lumos Labs.

Active
Registry status
NA
Development phase
816
Enrollment target
1
Study location

NCT05912556: Active NA study of Cognition and Brain Function, sponsored by Lumos Labs.

NCT05912556 is a NA study of Cognition and Brain Function that is active but no longer recruiting, run by Lumos Labs. The registered enrollment target is 816 participants, above the 148-participant average among 35 other Cognition trials with a reported enrollment target (451% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05912556, a NA study of Cognition and Brain Function, is active but no longer recruiting, sponsored by Lumos Labs.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
816 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to assess the effectiveness of two digital programs for providing mental stimulation, improving cognition, and inducing changes in brain structure and function.

Primary Outcome

The Overall Composite is derived from the 12 tests in the Creyos battery.

Conditions Studied

Cognition Brain Function Brain Structure Brain Health

Interventions

  • DEVICE Digital Program 1
  • DEVICE Digital Program 2

Study Locations (1)

California

  • Lumos Labs, Inc. - San Francisco

Trial Details

FieldValue
Enrollment Target 816 participants
Start Date 2023-07-05
Est. Completion 2025-05-15
Phase NA
Lumos Labs

9 total trials

What the registry record for NCT05912556 still lists

NCT05912556 is an interventional study that assigns participants to a tested intervention. The registered 816 participants enrollment target is mid-sized for trials with a published cap, above the 148-participant average among 35 other Cognition trials with a reported enrollment target (451% higher).

The record links to 4 conditions, with Cognition appearing as the primary indexed condition, and to 2 interventions - of which Digital Program 1 is the first listed.

NCT05912556 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05912556 about?

NCT05912556 is a clinical study titled "Brain Response to an Intervention Using Guided, At-Home Technology for the Mind". The objective of this study is to assess the effectiveness of two digital programs for providing mental stimulation, improving cognition, and inducing changes in brain structure and function.

What is the current status of trial NCT05912556?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 816 participants. The study started on 2023-07-05. Estimated completion is 2025-05-15.

What conditions does trial NCT05912556 study?

This clinical trial studies the following conditions: Cognition, Brain Function, Brain Structure, Brain Health.

What interventions are being tested in trial NCT05912556?

The interventions under investigation include: Digital Program 1 (DEVICE), Digital Program 2 (DEVICE).

Who is sponsoring clinical trial NCT05912556?

This trial is sponsored by Lumos Labs, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05912556 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cognition

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05912556's enrollment target sits among peer trials

816 3rd of 35 higher than 33 of 35 other Cognition trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cognition trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07218029 · 815 participants · Phase 3

    A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

  • NCT04846959 · 818 participants

    Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications

  • NCT04028687 · 820 participants

    MDR - PMCF Study for Taperloc Complete Stems

  • NCT04613440 · 820 participants · NA

    FaCT Trial (Facilitated Cascade Testing Trial)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT05912556, the US trial registry maintained by the National Library of Medicine. NCT05912556 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.